HomeArticlesToday's HighlightsProhost Outperforming Firms. What About ACHN?
Today's Highlights
Premium

Prohost Outperforming Firms. What About ACHN?

Biogen Idec (BIIB) : The FDA approved Biogen Idec drug Plegridy -- a long-acting multiple sclerosis drug expected to replace its older big-selling Avonex treatment. The drug is intended to reduce rela...
P

Prohost Biotech

1 min read
17
0

Unlock Premium Content

This article contains exclusive content for our premium subscribers. Join our community to access in-depth research, expert insights, and comprehensive analysis.

Unlimited articles
Expert analysis
Research reports

Comments (0)

Please sign in to join the discussion